http://www.biocryst.com
BioCryst Pharmaceuticals, Inc. Company Intro
BioCryst designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP).
Industry
Healthcare
BioCryst Pharmaceuticals, Inc. Headquaters
4505 Emperor Boulevard
Durham,27703
United States
BioCryst Pharmaceuticals, Inc. Share price
22 Jan 2021 01:12 GMT
$9.26
0.02 (0.22 %)
BioCryst Pharmaceuticals, Inc. Market cap
$1.615 B
WMC RANKING
2021
BioCryst Pharmaceuticals, Inc. # 99
BiotechnologyLatest BioCryst Pharmaceuticals, Inc. News
22 Jan 2021
Influenzavirus B Infection Drug Market 2020 | How The ...
BioCryst Pharmaceuticals Inc ... Daiichi Sankyo Company Ltd ... As a market research company, we take pride in equipping our clients with insights and data that ...
23 Jan 2021
InvestorChannel's Covid-19 Watchlist Update for Friday ...
Athersys Inc. (ATHX) USD 1.94 (6.01%)n- Takeda Pharmaceutical Company ... PLC (AZN) USD 53.25 (1.33%)n- BioCryst Pharmaceuticals Inc. (BCRX) USD ...
23 Jan 2021
Hereditary Angioedema Market New Business Experts Ideas By Pharming Group NV, Attune Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals
BIOCRYST PHARMACEUTICALS, INC – CSL ... Teva Pharmaceutical Industries, Ltd. – Attune Pharmaceuticals – KalVista Pharmaceuticals, Inc. The global ...
WMC Market Score
WMC Market to Revenue Score
BioCryst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioCryst Pharmaceuticals, Inc. | USD | $48,835 | $144,189 | $-108,897 | $16,150B | 99 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total BioCryst Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
BioCryst Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| BioCryst Pharmaceuticals, Inc. | 0.53 | 1.57 | 1.88 | 0 | 0 | 0 | 1.76 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
